Phlo Corporation, New York, NY, has commercialized a proprietary, patent-pending composition that has demonstrated in tests potent memory and cognition enhancement capabilities. Phlo has developed its cognition biotechnology into a personal performance preparation, which creates great focus and mental alertness without the secondary depression associated with the intake of stimulants. Additionally, this preparation meets another consumer desire through its strong appetite suppressant capabilities. Phlo will deliver the product in a two ounce spray, to be administered under the tongue, which will initially be offered in three flavors. The company also plans to add the biotechnology to its beverage products. These new spray products will be made available initially in the major distribution segments of chain and independent convenience stores, drug stores, mass merchandisers and supermarkets.